Overview

Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine

Status:
Completed
Trial end date:
2021-01-14
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the efficacy and safety of co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine in patients with primary hypercholesterolemia and essential hypertension.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Addpharma Inc.
Treatments:
Amlodipine
Ezetimibe
Rosuvastatin Calcium
Telmisartan
Telmisartan amlodipine combination
Criteria
Inclusion Criteria:

- Signed informed consent

- Subjects with hypertension and hyperlipidemia

Exclusion Criteria:

- Patient with known or suspected secondary hypertension

- Other exclusions applied